Heteroaryl chalcones: Mini review about their therapeutic voyage

Biomedicine and Preventive Nutrition

Volumn 4, Issue 3, 2014, Pages 451-458

  Mathew, Bijo ^a   Suresh, Jerad ^b   Anbazghagan, Sockalingam ^c   Paulraj, Jayaraj ^d   Krishnan, Girish K ^e  

^a Grace College of Pharmacy   (India)

^b MADRAS MEDICAL COLLEGE   (India)

^c Department of Pharmaceutical Chemistry   (India)

^d PERIYAR MANIAMMAI UNIVERSITY   (India)

^e GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Antimalarial; Benzimidazole chalcones; Chalcones; Claisen Schmidt condensation

Indexed keywords

1 (1H BENZIMIDAZOL 2 YL) 3 (3,4, 5 TRIMETHOXYPHENYL)PROP 2 EN 1 ONE; 1 (3 METHYLTHIOPHEN 2 YL) 3 [4 (PIPERIDIN 1 YL)PHENYL]PROP 2 EN 1 ONE; 1 (4 CHLOROPHENYL) 3 (FURAN 2 YL)PROP 2 EN 1 ONE; 1 (4 CHLOROPHENYL) 3 [5 (4 METHOXYPHENYL) FURAN 2 YL]PROP 2 EN 1 ONE; 1 FURAN 2 YL 3 PHENYL PROPENONE; 3 (4 BROMOPHENYL) 1 (THIOPHEN 2 YL)PROP 2 EN 1 ONE AND 3 (2 NITROPHENYL) 1 (THIOPHEN 2 YL) PROP 2 EN 1 ONE; 3 (5 CHLOROFURAN 2 YL) 1 (3 CHLOROPHENYL)PROP 2 EN 1 ONE; 3 PHENYL 1 THIOPHEN 2 YL PROPENONE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIINFECTIVE AGENT; BENZIMIDAZOLE DERIVATIVE; CHALCONE DERIVATIVE; FURAN DERIVATIVE; INDOLE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; THIAZOLE DERIVATIVE; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG;

ADDITION REACTION; ANTHELMINTIC ACTIVITY; ANTIANGIOGENIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; MALARIA FALCIPARUM; MEDICINAL CHEMISTRY; NONHUMAN; NUCLEOPHILICITY; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 84905965572     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2014.04.003     Document Type: Review

References (55)

1. Bukhari S.N.A., Jantan I., Jasamai M. Anti-inflammatory trends of 1, 3-diphenyl-2-propen-1-one derivatives. Mini Rev Med Chem 2013, 13:87-94.
2. Nowakowska Z. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 2007, 42:125-137.
3. Ni L., Meng C.Q., Sikorski J.A. Recent advances in therapeutic chalcones. Expert Opin Ther Pat 2004, 14:1669-1691.
4. Hayat F., Salahuddin A., Umar S., Azam A. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail. Eur J Med Chem 2010, 45:4669-4675.
5. Ingarsal N., Saravanan G., Amutha P., Nagarajan S. Synthesis, in vitro antibacterial and antifungal evaluations of 2-amino-4-(1-naphthyl)-6-arylpyrimidines. Eur J Med Chem 2007, 42:517-520.
6. Selvam T.P., Karthick V., Kumar P.V., Ali M. A. Antiepileptic activity of novel 2-(substituted benzylidene)-7-(4-fluorophenyl)-5-(furan-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H)-one derivatives. Lett Drug Des Discov 2013, 10:204-211.
7. Reddy V.M., Reddy K.R. Synthesis and biological evaluation of some novel-3-(5-substituted benzimidazole-2-yl)-5-aryl isoxazolines. Chin Chem Lett 2010, 21:1145-1148.
8. Kanagarajan V., Thanusu J., Gopalakrishnan M. Synthesis and in vitro microbiological evaluation of an array of biolabile 2-morpholino-N-(4, 6-diarylpyrimidin-2-yl) acetamides. Eur J Med Chem 2010, 45:1583-1589.
9. Dinkova-Kostova A.T., Abeygunawardana C., Talalay P. Chemoprotective properties of phenyl propenoids, bis (benzylidene) cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers. J Med Chem 1998, 41:5287-5296.
10. Mendes V., Monteiro R.R., Pestana D., Teixeira D., Calhau C.A.O., Azevedo I. Xanthohumol influences preadipocyte differentiation: Implication of antiproliferative and apoptotic effects. J Agric Food Chem 2008, 56:11631-11637.
11. Modzelewska A., Pettit C., Achanta G., Davidson N.E., Huang P., Khana S.R. Anticancer activities of novel chalcone and bis-chalcone derivatives. Bioorg Med Chem 2006, 14:3491-3495.
12. Reddy M.V.B., Su C.R., Chiou W.F., Liu Y.N., Chen R.Y.H., Bastow K.F., et al. Design, synthesis, and biological evaluation of mannich bases of heterocyclic chalcone analogs as cytotoxic agents. Bioorg Med Chem 2008, 16:7358-7370.
13. Vogel S., Ohmayer S., Brunner G., Heilman J. Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorg Med Chem 2008, 16:4286-4293.
14. Sharma A., Chakravarti B., Gupt M.P., Siddiqui J.A., Konwar R., Tripathi R.P. Synthesis and anti-breast cancer activity of biphenyl based chalcones. Bioorg Med Chem 2010, 18:4711-4720.
15. Nielsen S.F., Boesen T., Larsen M., Schønning K., Kromann H. Antibacterial chalcones-bioisosteric replacement of the 4'-hydroxy group. Bioorg Med Chem 2004, 12:3047-3054.
16. Boeck P., Leal P.C., Yunes R.A., Fiiho V.C., Lopez S., Sortino M., et al. Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones. Arch Pharm Chem Life Sci 2005, 338:87-95.
17. Wu J.H., Wang X.H., Yi Y.H., Lee K.H. Anti-AIDS agents 54, A potent anti-HIV chalcone and flavonoids from genus Desmos. Bioorg Med Chem Lett 2003, 13:1813-1815.
18. Lin Y.M., Zhou Y., Flavin M.T., Zhou L.M., Nie W., Chen F.C. Chalcones and flavonoids as anti-tuberculosis agents. Bioorg Med Chem 2002, 10:2795-2802.
19. Li R., Kenyon G.L., Cohen F.E., Chen X., Gong B., Dominguez J.N., et al. In vitro antimalarial activity of chalcones and their derivatives. J Med Chem 1995, 38:5031-5037.
20. Geyer J.A., Keenan S.M., Woodard C.L., Thompson P.A., Gerena L., Nichols D.A., et al. Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1, 3-diaryl-2-propenones. Bioorg Med Chem Lett 2009, 19:1982-1985.
21. Mishra N., Arora P., Kumar B., Mishra L.C., Bhattacharya A., Awasthi S.K., et al. Synthesis of novel substituted 1, 3-diaryl propenone derivatives and their antimalarial activity in vitro. Eur J Med Chem 2008, 43:1530-1535.
22. Kayser O., Kiderlen A.F. In vitro leishmanicidal activity of naturally occurring chalcones. Phytother Res 2001, 15:148-152.
23. Nielsen S.F., Chen M., Theander T.G., Kharazmi A., Christensen S.B. Synthesis of antiparasitic licorice chalcones. Bioorg Med Chem Lett 1995, 5:449-452.
24. Enoki T., Ohnogi H., Nagamine K., Kudo Y., Sugiyama K., Tanabe M. Antidiabetic activities of chalcones isolated from a Japanese herb, Angelica keiskei. J Agric Food Chem 2007, 55:6013-6017.
25. Damazio R.G., Zanatta A.P., Cazarolli L.H., Chiaradia L.D., Mascarello A., Nunes R.J., et al. Antihyperglycemic activity of naphthylchalcones. Eur J Med Chem 2010, 45:1332-1337.
26. Khatib S., Nerya O., Musa R., Shmuel M., Tamir S., Vaya J. Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety. Bioorg Med Chem 2005, 13:433-441.
27. Jun N., Hong G., Jun K. Synthesis and evaluation of 2', 4', 6'-trihydroxychalcones as a new class of tyrosinase inhibitors. Bioorg Med Chem 2007, 15:2396-2402.
28. Dong X., Du L., Pan Z., Liu T., Yang B., Hu Y. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents. Eur J Med Chem 2010, 45:3986-3992.
29. Utsintong M., Massarotti A., Caldarelli A., Theeramunkong S. Parallel synthesis of "Click" chalcones as antitubulin agents. Med Chem 2013, 9:510-516.
30. Sahu N.K., Balbhadra S.S., Choudhary J., Kohli D.V. Exploring pharmacological significance of chalcone scaffold: a review. Curr Med Chem 2012, 19:209-225.
31. Sharma V., Kumar V., Kumar P. Heterocyclic chalcone analogues as potential anticancer agents. Anticancer Agents Med Chem 2013, 13:422-433.
32. Mathew B., Suresh J., Anbazhagan S. Antitumor activity of 5-[(2E)-1-(1H- benzimidazol-2-yl)-3-substituted phenylprop-2-en-1-ylidene] pyrimidine-2, 4, 6(1H, 3H, 5H) triones against Dalton's Ascitic Lymphoma in mice. Med Chem Res 2013, 22:3911-3917.
33. Mathew B., Suresh A.J., Anbazhagan S. Synthesis and in silico design of some novel imines of 5-amino-1, 3, 4-thiadiazole-2-thiol linked to (1h-benzimidazole-2-yl) 3-substituted phenyl prop-2-enes. Indian J Heterocycl Chem 2013, 22:337-340.
34. De Vasconcelos A., Campos V.F., Nedel F., Seixas F.K., Dellagostin O.A., Smith K.R., et al. Cytotoxic and apoptotic effects of chalcone derivatives of 2-acetyl thiophene on human colon adenocarcinoma cells. Cell Biochem Funct 2013, 31:289-297.
35. Robinson S.J., Petzer J.P., Petzer A., Bergh J.J., Lourens A.C.U. Selected furanochalcones as inhibitors of monoamine oxidase. Bioorg Med Chem Lett 2013, 23:4985-4989.
36. Rizvi S.U.F., Siddiqui H.L., Johns M., Detorio M., Schinazi R.F. Anti-HIV-1 and cytotoxicity studies of piperidyl-thienyl chalcones and their 2-pyrazoline derivatives. Med Chem Res 2012, 21:3741-3749.
37. Solomon V.R., Lee H. Anti-breast cancer activity of heteroaryl chalcone derivatives. Biomed Pharmacother 2012, 66:213-220.
38. Lee J.S., Kang Y., Kim J.T., Thapa D., Lee E.S., Kim J.E. The anti-angiogenic and antitumor activity of synthetic phenylpropenone derivatives is mediated through the inhibition of receptor tyrosine kinases. Eur J Pharmacol 2012, 67:22-30.
39. Nguyen T.T.N., Do T.H., Huynh T.N.P., Tran C.D.T., Thai K.M. Synthesis and antibacterial activity of some heterocyclic chalcone analogues alone and in combination with antibiotics. Molecules 2012, 17:6684-6696.
40. Zheng C.J., Jiang S.M., Chen Z.H., Ye B.J., Piao H.R. Synthesis and antibacterial activity of some heterocyclic chalcone derivatives bearing thiofuran, furan, and quinoline moieties. Arch Pharm Chem Life Sci 2011, 344:689-695.
41. Ramesh B., Rao B.S. Synthesis, spectral studies and anti-inflammatory activity of 2-acetyl thiophene. Eur J Chem 2010, 7:433-436.
42. Bag S., Ramar E.S., Degani M.S. Synthesis and biological evaluation of a, b-unsaturated ketone as potential antifungal agents. Med Chem Res 2009, 18:309-316.
43. Shi H.B., Zhang S.J., Ge Q.F., Guo D.W., Cai C.M., Hua W.X. Synthesis and anticancer evaluation of thiazolyl-chalcones. Bioorg Med Chem Lett 2010, 20:6555-6559.
44. Zahran M.A.H., Ibrahim A.M. Synthesis and cellular cytotoxicities of new N-substituted indole-3-carbaldehyde and their indolylchalcones. J Chem Sci 2009, 121:455-462.
45. Kumar D., Kumar N.M., Akamatsu K., Kusaka E., Harada H., Ito T. Synthesis and biological evaluation of indolyl chalcones as antitumor agents. Bioorg Med Chem Lett 2010, 20:3916-3919.
46. Cui M., Ono M., Kimura H., Liu B.L., Saji H. Synthesis and biological evaluation of indole chalcone derivatives as β-amyloid imaging probe. Bioorg Med Chem Lett 2011, 21:980-982.
47. Nofal Z.M., Soliman E.A., Karim S.S.A., Sethumadavan S., Maher T.J. Novel benzimidazole derivatives as expected anticancer agents. Act Polon Pharma Drug Res 2011, 68:519-534.
48. Ouattara M., Sissouma D., Koné M.W., Menan H.E., Touré S.A., Ouattara L. Synthesis and anthelmintic activity of some hybrid benzimidazolyl-chalcone derivatives. Trop J Pharm Res 2011, 10:767-775.
49. Mathew B., Unnikrishnan G., Shafeer V.P., Muhamed M.C., Femina P. Microwave assisted synthesis, physicochemical properties and antimicrobial activity of benzimidazole chalcones. Der Pharma Chemica 2011, 3:627-631.
50. Domýngueza J.N., Charris J.E., Loboa G., de Domýnguezb N.G., Moreno M.M., Riggione F., et al. Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity. Eur J Med Chem 2001, 36:555-560.
51. Chikhalia K.H., Patel M.J., Vashi D.B. Design, synthesis and evaluation of novel quinolyl chalcones as antibacterial agents. ARKIVOC 2008, XIII:189-197.
52. Kotra V., Ganapathy S., Adapa S.R. Synthesis of new quinolinyl chalcones as anticancer and anti-inflammatory agents. Indian J Chem 2010, 49B:1109-1116.
53. Hayat F., Moseley E., Salahuddin A., Zyl R.L.V., Azam A. Antiprotozoal activity of chloroquinoline based chalcones. Eur J Med Chem 2011, 46:1897-1905.
54. Abonia R., Insuasty D., Castillo J., Insuasty B., Quiroga J., Nogueras M., et al. Synthesis of novel quinoline-2-one based chalcones of potential antitumor activity. Eur J Med Chem 2012, 57:29-40.
55. Tseng C.H., Chen L.C., Hsu C.Y., Chen T.C., Cheng C.M., Tso H.C., et al. Synthesis and antiproliferative evaluation of 3-phenylquinolinylchalcone derivatives against non-small cell lung cancers and breast cancers. Eur J Med Chem 2013, 59:274-382.